CONSUN PHARMAC.GR.HD -10 Working Capital to Net Assets Ratio
CONSUN PHARMAC.GR.HD -10 working capital to net assets ratio. CONSUN PHARMAC.GR.HD -10 (C1P) has a Working Capital to Net Assets ratio of 65.6% as of December 2025. Working capital of €3.17 Billion (current assets of €4.60 Billion minus current liabilities of €1.43 Billion) is measured against net assets of €4.84 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check C1P intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of CONSUN PHARMAC.GR.HD -10 (2021–2025)
Working capital to net assets ratio of CONSUN PHARMAC.GR.HD -10 from 2021 to 2025. This chart shows how CONSUN PHARMAC.GR.HD -10's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 65.6%, reflecting working capital of €3.17 Billion against net assets of €4.84 Billion EUR. See operational self-sufficiency of CONSUN PHARMAC.GR.HD -10 to measure how many days the company can operate on defensive assets alone.
CONSUN PHARMAC.GR.HD -10 Working Capital to Net Assets Ratio by Year (2021–2025)
CONSUN PHARMAC.GR.HD -10 working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for CONSUN PHARMAC.GR.HD -10 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see C1P asset base.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 65.6% | €3.17 Billion | €4.84 Billion | €4.60 Billion | €1.43 Billion | ▼ -6.8 pp |
| 2024 | 72.4% | €3.18 Billion | €4.39 Billion | €4.55 Billion | €1.37 Billion | ▲ +1.4 pp |
| 2023 | 71.0% | €2.78 Billion | €3.92 Billion | €4.28 Billion | €1.49 Billion | ▲ +4.9 pp |
| 2022 | 66.1% | €2.27 Billion | €3.44 Billion | €3.62 Billion | €1.35 Billion | ▲ +7.7 pp |
| 2021 | 58.3% | €1.70 Billion | €2.91 Billion | €3.06 Billion | €1.36 Billion | — |